EHMT2 and cancer: G9a is also noted to be implicated in mediating the DNA repair through efficient homologous recombination, which make cancer cells more resistant to radiation and chemotherapies; therefore, inhibition of G9a catalytic activity to interfere DNA repair pathways is a rational therapeutic strategy against cancers27.